Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

An update on uremic toxins

S Ringoir1

  • 1University of Ghent, Belgium.

Kidney International. Supplement
|November 14, 1997
PubMed
Summary
This summary is machine-generated.

This review examines the evolving understanding of uremic toxins, focusing on biochemical methods, clinical signs, and experimental models. It assumes each toxin has a distinct toxic effect.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Bio-artificial organs].

Verhandelingen - Koninklijke Academie voor Geneeskunde van Belgie·2004
Same author

In vitro effect of cefodizime, imipenem/cilastatin and co-trimoxazole on dexamethasone and cyclosporin A depressed phagocytosis.

Infection·1998
Same author

Binding of indole-3-acetic acid to human serum albumin and competition with L-tryptophan.

Clinica chimica acta; international journal of clinical chemistry·1998
Same author

P-Cresol, a uremic compound, enhances the uptake of aluminum in hepatocytes.

Journal of the American Society of Nephrology : JASN·1997
Same author

Serum uremic toxins from patients with chronic renal failure displace the binding of L-tryptophan to human serum albumin.

Clinica chimica acta; international journal of clinical chemistry·1997
Same author

HPLC fractions of human uremic plasma inhibit the RBC membrane calcium pump.

Kidney international·1997
Same journal

Effect of kidney disease on glucose handling (including genetic defects).

Kidney international. Supplement·2011
Same journal

Need for better diabetes treatment for improved renal outcome.

Kidney international. Supplement·2011
Same journal

Glucose dynamics and mechanistic implications of SGLT2 inhibitors in animals and humans.

Kidney international. Supplement·2011
Same journal

SGLT2 inhibitors: molecular design and potential differences in effect.

Kidney international. Supplement·2011
Same journal

Glucose handling by the kidney.

Kidney international. Supplement·2011
Same journal

Bone: from a reservoir of minerals to a regulator of energy metabolism.

Kidney international. Supplement·2011
See all related articles

Area of Science:

  • Biochemistry
  • Nephrology
  • Toxicology

Background:

  • Uremic toxins are implicated in the progression of kidney disease.
  • Understanding their specific roles is crucial for effective treatment.

Purpose of the Study:

  • To review the historical development and current trends in the study of uremic toxins.
  • To analyze advancements in biochemical methodologies, clinical symptom descriptions, and experimental models.
  • To examine the evolution of definitions for uremic toxins.

Main Methods:

  • Literature review of trends and evolution in the field.
  • Analysis of biochemical methodologies.
  • Examination of clinical symptomatology and experimental models.

Related Experiment Videos

Main Results:

  • Significant evolution in biochemical techniques for identifying and quantifying uremic toxins.
  • Improved clinical descriptions of uremic syndrome symptoms.
  • Development of more sophisticated experimental models for studying toxin effects.

Conclusions:

  • The field has progressed significantly in understanding uremic toxins.
  • A key assumption is that individual toxins exert specific toxic effects.
  • Continued research is needed to refine definitions and therapeutic strategies.